New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants

Overview of attention for article published in BMC Medicine, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 13 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing.

Article in Allergy & Asthma Proceedings (March 2024)

Respiratory syncytial virus immunoprophylaxis: Novel opportunities and a call for equity

Article in Journal of Medical Virology (February 2024)

The road to approved vaccines for respiratory syncytial virus

Article in npj Vaccines (September 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.